Hansa Biopharma AB Share Price Deutsche Boerse AG
Equities
24H
SE0002148817
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.798 EUR | +12.70% | +13.85% | +54.89% |
21/05 | Hansa Biopharma to Present Data At 2024 American Transplant Congress Annual Meeting | CI |
18/04 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 |
Sales 2024 * | 239M 22.4M 20.75M 1.87B | Sales 2025 * | 343M 32.09M 29.71M 2.68B | Capitalization | 2.7B 252M 234M 21.04B |
---|---|---|---|---|---|
Net income 2024 * | -735M -68.83M -63.74M -5.74B | Net income 2025 * | -712M -66.68M -61.75M -5.56B | EV / Sales 2024 * | 13.2 x |
Net Debt 2024 * | 474M 44.39M 41.11M 3.7B | Net Debt 2025 * | 733M 68.68M 63.6M 5.73B | EV / Sales 2025 * | 10 x |
P/E ratio 2024 * |
-3.7
x | P/E ratio 2025 * |
-4.39
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.64% |
Latest transcript on Hansa Biopharma AB
1 day | +12.70% | ||
1 week | +13.85% | ||
Current month | +58.25% | ||
1 month | +64.99% | ||
3 months | +41.08% | ||
6 months | +73.11% | ||
Current year | +54.89% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Tulstrup
CEO | Chief Executive Officer | 59 | 20/18/20 |
Hitto Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/12 |
Achim Kaufhold
CTO | Chief Tech/Sci/R&D Officer | 66 | 29/20/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 29/18/29 | |
Peter Nicklin
CHM | Chairman | 61 | 30/22/30 |
Mats Blom
BRD | Director/Board Member | 59 | 22/19/22 |
Date | Price | Change |
---|---|---|
29/24/29 | 3.798 | +12.70% |
28/24/28 | 3.37 | -3.82% |
27/24/27 | 3.504 | -4.16% |
24/24/24 | 3.656 | +3.16% |
23/24/23 | 3.544 | +6.24% |
Delayed Quote Deutsche Boerse AG, May 29, 2024 at 12:56 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.67% | 58.71B | |
-2.76% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.25% | 26.55B | |
-23.10% | 18.98B | |
+1.88% | 12.51B | |
+26.43% | 12.08B | |
+21.74% | 11.94B |
- Stock Market
- Equities
- HNSA Stock
- 24H Stock